Key points are not available for this paper at this time.
Next-generation sequencing approaches promise to become the future standard for drug-susceptibility testing and epidemiological investigation in tuberculosis and for other high-priority bacterial pathogenshttp://ow.ly/kXsV30lLP78
Cabibbe et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: